$3M Tax Break Promise Convinces OSI Pharma to Consolidate, Expand in NYC Suburb | GenomeWeb

By Alex Philippidis

WHITE PLAINS, NY — OSI Pharmaceuticals this week was promised $3 million in sales tax breaks from New York state and Westchester County governments to help pay for its $100 million consolidation of its US operations and expansion in Greenburgh, NY.

At the same time, additional details emerged about the tax incentives and about the search that ended in the New York City suburb located less than an hour's drive north of Manhattan.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.